Skip to main content
TipRanks
Go Ultimate75% OFF

Top Page

SAWS

AAM Sawgrass US Small Cap Quality Growth ETF (SAWS)

Rating:68Neutral
Price Target:$23.00â–²(4.31% Upside)

SAWS, the AAM Sawgrass US Small Cap Quality Growth ETF, earns a solid overall rating thanks to several strong growth-focused holdings like Iradimed, Mueller Industries, CareDx, Digi International, and Gorman-Rupp, which show robust financial performance, positive earnings sentiment, and generally supportive technical trends. However, more leveraged and operationally challenged names such as Guardian Pharmacy Services and StoneX Group, along with some holdings facing high valuations and overbought conditions, slightly temper the fund’s appeal and highlight risks around financial leverage and potential short-term volatility.

Positive Factors
Strong Year-To-Date PerformanceThe ETF has delivered positive returns so far this year, showing resilience despite recent short-term weakness.
Winning Top HoldingsMost of the largest positions have shown strong gains this year, helping support the fund’s overall performance.
Broad Sector MixHoldings spread across health care, industrials, technology, financials, and several other sectors help reduce the impact of trouble in any single industry.
Negative Factors
Recent Performance WeaknessThe ETF has seen notably weak returns over the last one and three months, which may signal short-term pressure on small-cap growth stocks.
High U.S. ConcentrationWith almost all assets in U.S. companies, the fund offers little geographic diversification and is heavily tied to the U.S. economy and market conditions.
Above-Average Expense RatioThe fund’s fee is on the higher side for an ETF, which means more of the returns are eaten up by costs over time.

SAWS vs. SPDR S&P 500 ETF (SPY)

-5%0%5%10%15%20%25%30%SPY+14.55%SAWS+9.63%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AUM
6.94M
Region
North America
Expense Ratio
0.55%
Beta
0.80
Issuer
AAM
Inception Date
Jul 30, 2024
Dividend Yield
0.02%
Asset Class
Equity
Index Tracked
No Underlying Index

SAWS Summary

SAWS is the AAM Sawgrass US Small Cap Quality Growth ETF, focused on smaller U.S. companies that aim for strong, long-term growth rather than following a specific index. It invests across many sectors, including health care, industrials, and technology, and holds companies like Pricesmart and Sanmina-Sci. Someone might consider SAWS to add diversification and growth potential from up-and-coming businesses that are not yet large household names. However, because it invests in small companies, the share price can be more volatile and may go up and down more sharply than funds focused on larger, more established firms.

How much will it cost me?

This ETF has an expense ratio of 0.55%, which means you’ll pay about $5.50 per year for every $1,000 you invest. That’s higher than the average ETF because it’s actively managed, focusing on a specialized group of small-cap growth companies rather than simply tracking a broad market index.

What would affect this ETF?

Future performance of SAWS will benefit if the U.S. economy stays healthy, supporting small, fast-growing companies in sectors like health care, industrials, and technology, and if innovation and demand for medical and tech solutions remain strong. On the downside, rising interest rates, an economic slowdown in the U.S., or tighter regulations in health care and financial services could hurt small-cap growth stocks and make this ETF more volatile.

SAWS Top 10 Holdings

SAWS is leaning heavily into U.S. small-cap health care and tech, and that’s where most of the action is. CareDx has been a standout, rising sharply and giving the fund a strong growth engine, while Bioventus and Digi International add more steady-to-rising momentum on the innovation side. On the flip side, Iradimed and Mueller Industries have been lagging, acting like a bit of sand in the gears. With all holdings U.S.-based and several health care names near the top, the ETF is clearly betting on domestic, high-growth medical and tech stories.

SAWS top ten holdings
NameCompany NameWeight %Market ValueMarket CapYearly GainOverall Rating
BTSGBTSGBrightSpring Health Services, Inc.3.64%$252.57K$14.22B124.28%67Neutral
PSMTPSMTPricesmart3.13%$217.12K$5.09B41.91%77Outperform
SNEXSNEXStoneX Group3.05%$211.30K$6.89B44.86%58Neutral
PTRNPTRNPattern Group, Inc. Class A2.71%$188.15K$3.70B14.75%――
DGIIDGIIDigi International2.59%$179.45K$2.22B43.86%77Outperform
AGLAGLAgilon Health2.54%$176.12K$1.85B667.99%42Neutral
OSCROSCROscar Health2.40%$166.39K$9.86B122.58%49Neutral
GRCGRCGorman-Rupp Company2.49%$172.44K$1.85B52.50%76Outperform
CDNACDNACareDx2.36%$163.56K$4.19B390.74%77Outperform
LFSTLFSTLifestance Health Group2.15%$149.19K$5.38B123.14%61Neutral

SAWS Technical Analysis

Technical Analysis SentimentNegative
Last Price22.05

Price Trends

50DMA22.67Negative
100DMA23.60Negative
200DMA23.22Negative

Market Momentum

MACD-0.19Negative
RSI45.44Neutral
STOCH74.21Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SAWS, the sentiment is Negative. The current price of 22.05 is below the 20-day moving average (MA) of 22.19, below the 50-day MA of 22.67, and below the 200-day MA of 23.22, indicating a bearish trend. The MACD of -0.19 indicates Negative momentum. The RSI at 45.44 is Neutral, neither overbought nor oversold. The STOCH value of 74.21 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SAWS.

SAWS Peer Comparison

Comparison Results

SAWS against its peer funds
NamePricePrice TargetAUMExpense RatioOverall Rating
SAWSSAWS$22.05$23.00(4.31% Upside)$6.94M0.55%68Neutral
ACSGACSG$45.91$62.62(36.40% Upside)$52.99M0.49%64Neutral
TMFSTMFS$34.54$43.57(26.16% Upside)$52.83M0.85%63Neutral
MMSCMMSC$26.19$33.35(27.34% Upside)$52.26M0.95%63Neutral
SGRWSGRW$24.67$35.15(42.52% Upside)$27.93M0.80%60Neutral
FSEGFSEG$25.77$35.49(37.72% Upside)$7.91M0.28%62Neutral

Performance Comparison

-10%0%10%20%30%SAWSACSGTMFSMMSCSGRWFSEGDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
SAWS and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
SAWSAAM Sawgrass US Small Cap Quality Growth ETF22.051.959.70%
ACSGAmerican Century Small Cap Growth Insights ETF45.917.1018.28%
TMFSMotley Fool Small-Cap Growth ETF34.541.815.52%
MMSCFirst Trust Multi-Manager Small Cap Opportunities ETF26.193.6015.94%
SGRWHarbor Active Small Cap Growth ETF24.674.3721.55%
FSEGFidelity Enhanced Small Cap Growth ETF25.770.542.14%
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.